TU 199 (CID 636411) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(28)
 
 
Inactive(34)
 
 
Inconclusive(34)
 
 
Unspecified(4)
 
 
Top Targets:
pantethn trn(2)
 
 
PMP22 Claudin(2)
 
 
NR LBD ROR li..(2)
 
 
Menin(2)
 
 
Geminin(2)
 
 
 
BioAssay Types:
Literature(62)
 
 
 
 
 
Confirmatory(30)
 
 
 
 
Screening(2)
 
 
BioActivity Types:
Potency(29)
 
 
 
 
IC50(4)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 39    Data Row: 100   Total Pages: 2   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID160693324]
IC50 0.224HARVARD: Inhibition of liver stage Plasmodium berghei infection in HepG2 cells [AID685501, Type: other]
View
2
[SID50112774]
Potency 8.4921Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
3
[SID50112774]
Potency 9.5283Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory]
View
4
[SID50112774]
Potency 18.6892Confirmation qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID2701, Type: confirmatory]phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339]
View
5
[SID144206071]
Potency 26.6086qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
6
[SID144206071]
Potency 26.6086qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
7
[SID144206071]
Potency 26.6086qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
8
[SID50112774]
Potency 44.6684Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
9
[SID50112774]
Potency 44.6684Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
10
[SID50112774]
Potency 44.6684Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
11
[SID50112774]
Potency 44.6684Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory]vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845]
View
12
[SID50112774]
Potency 44.6684qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase) [AID1490, Type: confirmatory]phosphopantetheinyl transferase [Bacillus subtilis] [gi:10954339]
View
13
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_7, Type: Literature]
View
14
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_3, Type: Literature]
View
15
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_4, Type: Literature]
View
16
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_55, Type: Literature]
View
17
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_56, Type: Literature]
View
18
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_57, Type: Literature]
View
19
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_46, Type: Literature]
View
20
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_52, Type: Literature]
View
21
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_53, Type: Literature]
View
22
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_13, Type: Literature]
View
23
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_15, Type: Literature]
View
24
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_18, Type: Literature]
View
25
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_19, Type: Literature]
View
26
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_26, Type: Literature]
View
27
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_32, Type: Literature]
View
28
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_35, Type: Literature]
View
29
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_39, Type: Literature]
View
30
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_42, Type: Literature]
View
31
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_10, Type: Literature]
View
32
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_11, Type: Literature]
View
33
[SID92309022]
 A screen for compounds that inhibit liver stage malaria [AID624349, Type: other]
View
34
[SID160693324]
IC50 5HARVARD: Inhibition of blood stage Plasmodium falciparum 3D7 infection [AID685502, Type: other]
View
35
[SID160693324]
IC50 5HARVARD: Inhibition of blood stage Plasmodium falciparum Dd2 infection [AID685503, Type: other]
View
36
[SID160693324]
IC50 10HARVARD: Cytotoxicity in HepG2 cell line [AID685500, Type: other]
View
37
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature]
View
38
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_59, Type: Literature]
View
39
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_50, Type: Literature]
View
40
[SID92309022]
 A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus [AID651828, Type: other]Nucleoprotein [gi:127925]
View
41
[SID50112774]
Potency qHTS of Trypanosoma Brucei Inhibitors [AID624173, Type: confirmatory]hypothetical protein, conserved [Trypanosoma brucei] [gi:62359610]
View
42
[SID50112774]
Potency qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory]heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549]
View
43
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_5, Type: Literature]
View
44
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_2, Type: Literature]
View
45
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_9, Type: Literature]
View
46
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_45, Type: Literature]
View
47
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_38, Type: Literature]
View
48
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_41, Type: Literature]
View
49
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_36, Type: Literature]
View
50
[SID50112774]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_12, Type: Literature]
View